IPWatchdog.com is in the process of transitioning to a newer version of our website. Please be patient with us while we work out all the kinks.

Episode 6: Representative Henry Waxman

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/7328348/height/45/theme/standard/thumbnail/no/direction/forward/” width=”100%” height=”45″ scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” use_download_link=”” download_link_text=”” primary_content_url=”http://traffic.libsyn.com/clause8/Clause_8_-_Episode_6_-_Henry_Waxman_REVISED.mp3″ theme=”standard” custom_color=”87a93a” libsyn_item_id=”7328348″ /]Former Congressman Waxman discusses the passage of the seminal Hatch-Waxman Act, recent proposals to improve the balance between rights of brand name pharmaceutical and generic companies, and his 40-year career in Congress.

Share

Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author as of the time of publication and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com. Read more.

Join the Discussion

No comments yet.